跳转至内容
Merck
CN

857346P

Avanti

VPC 44116

Avanti Research - A Croda Brand

别名:

(R)-(3-氨基-4-((3-辛基酚)氨基)-4-氧丁基)膦酸

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C18H31N2O4P
化学文摘社编号:
分子量:
370.42
UNSPSC代码:
12352211
NACRES:
NA.25
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

VPC 44116, Avanti Research - A Croda Brand 857346P, powder

方案

>99% (TLC)

表单

powder

包装

pkg of 1 × 1 mg (857346P-1mg)

制造商/商品名称

Avanti Research - A Croda Brand 857346P

脂质类型

cardiolipins
sphingolipids

运输

dry ice

储存温度

−20°C

SMILES字符串

CCCCCCCCC1=CC(NC([C@H](N)CCP(O)(O)=O)=O)=CC=C1

一般描述

除了受体选择性激动剂(例如 SEW2871)外,竞争性 S1P 受体拮抗剂还可用于研究 S1P 信号传导(特别是涉及 S1P1 信号传导)的生理效应。(R)-3-氨基-(3-辛基苯基氨基)-4-氧代丁基膦酸(VPC44116)(S1P1/3 拮抗剂)和类似物(R)-3-氨基-(3-己基苯基氨基)-4-氧代丁基膦酸( W146)(S1P1 拮抗剂),通过在小鼠肺组织中进行伊文思蓝染料渗漏检测发现两者均可增加毛细血管的通透性。该产品受专利号 US 7,888,527 B2 的保护。Avanti 经弗吉尼亚大学许可制造

包装

5 mL 琥珀色玻璃螺旋盖小瓶(857346P-1mg)

法律信息

Avanti Research is a trademark of Avanti Polar Lipids, LLC

储存分类代码

13 - Non Combustible Solids

WGK

WGK 3


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
Sanna MG, et al.
Nature Chemical Biology, 2, 434-441 (2006)
Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.
Kennedy PC, et al.
Journal of Pharmacology and Experimental Therapeutics, 338, 879-889 (2011)
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.
Foss FW Jr, et al.
Bioorganic & Medicinal Chemistry, 15, 663-677 (2007)
Perry C Kennedy et al.
The Journal of pharmacology and experimental therapeutics, 338(3), 879-889 (2011-06-03)
Sphingosine 1-phosphate (S1P) is a phospholipid that binds to a set of G protein-coupled receptors (S1P(1)-S1P(5)) to initiate an array of signaling cascades that affect cell survival, differentiation, proliferation, and migration. On a larger physiological scale, the effects of S1P
Frank W Foss et al.
Bioorganic & medicinal chemistry, 15(2), 663-677 (2006-11-23)
The synthesis of N-arylamide phosphonates and related arylether and arylamine analogues provided potent, subtype-selective agonists and antagonists of the five known sphingosine 1-phosphate (S1P) receptors (S1P(1-5)). To this end, the syntheses of phosphoserine mimetics-selectively protected and optically active phosphonoserines-are described.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持